We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Results 1 to 5 of 7
Most popular |Most recent

Biosimilars: Supreme Court Grants Certiorari in Amgen v. Sandoz

USA - January 20 2017 On Friday, January 13, the Supreme Court granted certiorari in Amgen v. Sandoz (Nos. 15-1039 & 15-1195). The Supreme Court originally deferred its...

Amy E. Hayden, Ph.D..

Intellectual property bulletin summer 2015

USA - September 30 2015 As the number and complexity of cross-border and multi-jurisdictional disputes increase, companies can use 28 U.S.C. 1782 to obtain evidence from U...

David Tellekson, Guinevere Jobson, Charlene M. Morrow.

Even Spider-Man can't defeat ban on post-patent expiration royalties

USA - June 24 2015 Fifty years ago, in Brulotte v. Thys Co., the U.S. Supreme Court held that "a patentee's use of a royalty agreement that projects beyond the...

David Tellekson.

Supreme Court rules on reverse payment settlements in Federal Trade Commission v Actavis Inc

USA - June 17 2013 Today, the U.S. Supreme Court held in Federal Trade Commission v. Actavis, Inc. that so-called "reverse payment" settlement agreements should be...

David Tellekson.

US Supreme Court to weigh in on reverse payment deals

USA - April 2 2013 On March 25, 2013, the U.S. Supreme Court heard oral argument in FTC v. Actavis, Inc., which is on appeal from the U.S. Court of Appeals for the...

David Tellekson.